companyprofile

Actions

Jana Medical Co.

Companies with accumulated losses of 35% to less than 50% of its capital'

9616
JANA
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Main Market
  • Health Care Equipment & Svc     

Stats Overview

  • Prev. Close -
  • Open N/A
  • High
  • Low
  • No. of Trades
  • Avg. Trade size* N/A
  • Volume Traded
  • Value Traded (^)

Performance

JANA
- ( - )
Compare
Name Price Change %
Jana Medical Co. -
Note: Prices are delayed minimum 5 minutes
  • *Average Trade Size = Cumulative / # of Trades
  • **52 Week Price Change =   (Current Price - Price year ago) / Price year ago x 100
  • Historical prices & volume traded data are adjusted to account for all corporate actions.
  • MO: Market Order

Trade Updates

Last Trade

Price
-
% Change
-
Volume Traded
0

Best Bid

Price -
Volume -

Best Offer

Price -
Volume -

52 WEEK

High
45.00
2024/12/18
Low
17.32
2025/04/30
Change**
0.0

PERFORMANCE

Start of Year
Year ago
3 Years ago

Compare Selected

Select a Maximum of 5 Companies

Compare Selected

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions
NO PORTLET SESSION YET

AnnouncmentandCorporateAction

Actions
Jump To :
  • Announcements & Corporate Actions
  • Dividends
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Announcements

  • Jana Medical Company Announces the Award of a Contract for the Supply and Installation of Field Hospitals and Mobile Clinics Worth SAR 49,619,730

    9616
    JANA -1.77 %
    1446/10/18     16/04/2025 15:37:59
  • Jana Medical Co. Announces its accumulated loses reaching 40.55 % of its capital

    9616
    JANA -1.77 %
    1446/10/09     07/04/2025 08:35:07
  • Jana Medical Co. announces its Annual Financial results for the period ending on 2024-12-31

    9616
    JANA -1.77 %
    1446/09/27     27/03/2025 16:41:03
  • Jana Medical Company announces the signing of an agreement with Afaq Financial Company as a financial advisor to arrange the process of offering and listing the shares of Elite Medical Care Company and Excellent Care Company (fully owned by Jana medical company) in the Parallel Market (Nomu).

    9616
    JANA -1.77 %
    1446/09/18     18/03/2025 15:33:30
  • Jana Medical Company Announces the Conversion of Two Branches into Limited Liability Companies

    9616
    JANA -1.77 %
    1446/09/06     06/03/2025 16:04:48
View All

Corporate Actions

Upcoming Events

    Past Events

      Jump To :
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Dividends

      Announced Date Eligibility Date Distribution Date Distribution Way Dividend Amount

      CompanyProfilev2Financials

      Actions
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Financials

      • FINANCIAL INFORMATION
      • FINANCIAL STATEMENTS AND REPORTS
      • Annually
      • Quarterly
      Balance Sheet 2024-12-31 2023-12-31 2022-12-31
      Total Assets
      84,658.58
      77,882.71
      63,183.98
      -
      Total Liabilities
      45,336
      41,620.02
      32,571.93
      -
      Total Shareholders Equity (After Deducting the Minority Equity)
      39,322.57
      36,262.68
      30,612.04
      -
      Total Liabilities and Shareholders Equity
      84,658.58
      77,882.71
      63,183.98
      -
      Statement of Income 2024-12-31 2023-12-31 2022-12-31
      Total Revenue (Sales/Operating)
      36,708
      61,360.4
      43,045.43
      -
      Net Profit (Loss) before Zakat and Tax
      -21,754.09
      6,545.2
      5,561.12
      -
      Zakat and Income Tax
      -1,418.99
      -1,130.44
      -337.29
      -
      Net Profit (Loss) after Zakat and Tax
      -23,173.09
      5,414.75
      5,223.82
      -
      Total Comprehensive Income
      -22,989.56
      5,650.64
      4,832.04
      -
      Profit (Loss) per Share
      -8.74
      2.11
      2.6
      -
      Cash Flows 2024-12-31 2023-12-31 2022-12-31
      Net Cash From Operating Activities
      5,325.7
      3,923.66
      -36,405.38
      -
      Net Cash From Investing Activities
      -39.89
      -239.45
      -364.42
      -
      Net Cash From Financing Activities
      10,974.6
      -3,634.97
      37,339.3
      -
      Cash and Cash Equivalents, Beginning of the Period
      1,057
      1,007.78
      477.25
      -
      Cash and Cash Equivalents, End of the Period
      17,317.43
      1,057.02
      1,007.78
      -
      All Figures in Thousands Thousands Thousands
      All Currency In ^ ^ ^
      Last Update Date 2025-03-31 2024-12-03 2024-12-05

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Balance Sheet
      Total Assets
      Total Liabilities
      Total Shareholders Equity (After Deducting the Minority Equity)
      Total Liabilities and Shareholders Equity
      Statement of Income
      Total Revenue (Sales/Operating)
      Net Profit (Loss) before Zakat and Tax
      Zakat and Income Tax
      Net Profit (Loss) after Zakat and Tax
      Total Comprehensive Income
      Profit (Loss) per Share
      Cash Flows
      Net Cash From Operating Activities
      Net Cash From Investing Activities
      Net Cash From Financing Activities
      Cash and Cash Equivalents, Beginning of the Period
      Cash and Cash Equivalents, End of the Period
      All Figures in
      All Currency In
      Last Update Date

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Display Previous Periods
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Shareholding Information

      • Board Of Directors
      • Foreign Ownership
      • Substantial Shareholders
      Time Period
      -
      Search
      Trading Date Shareholders Designation Shares Held Trading Day Shares Held Prev Trading Day Change
      2025-04-30 عيد سلطان عايد العتيبي Chairman 11.2145992% 11.2145992% 0
      2025-04-30 فهد مشعل ممدوح سليمان العلي Board of Directors 0.5094163% 0.5094163% 0
      2025-04-30 مشاري ثواب مطر المطيري Board of Directors 1.2451362% 1.2451362% 0
      2025-04-30 جميل مثيب وقيان النفيعي العتيبي Senior Executives 1.0894942% 1.0894942% 0
      2025-04-30 جميل مثيب وقيان النفيعي العتيبي Board of Directors 1.0894942% 1.0894942% 0
      2025-04-30 عبدالله ناصر بدر البدر Board of Directors 0.7263813% 0.7263813% 0
      2025-04-30 جمال مثيب وقيان العتيبي Board of Directors 1.3834708% 1.3834708% 0
      • The listed company (Publisher) shall be responsible for the accuracy of the published information pertaining to the ownership of the Board of Directors, Chief Executive Officer or highest executive position, and the Chief Financial Officer. The listed company shall also be responsible for updating these information thereof. Therefore, the Saudi Stock Exchange (Tadawul) shall not be liable for the information contained therein, nor for any consequences that may result from the said information.
      for
      subs
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Peer Comparison

      • Table
      • Graphical
      Add Company

      Compare Selected

      Select a Maximum of 5 Companies

      Company Apply
      Jana Medical Co.
      Price -
      Market Cap (^ MN)
      P/E Ratio -
      Index Name Index Level 1D Return
      Jana Medical Co. %
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Company Profile

      Company overview

      The company works in the field of importing and supplying medical devices, equipment and supplies to hospitals in the government and private sectors, and the company has (2) subsidiary companies bearing the name (Elite Medical Care Company - and Excellent Medical Care Company) and all of them work in the same medical field.

      Company History

      The company was established in 2016 and the company works in the field of importing and supplying medical devices, equipment and supplies, and the company has (2) subsidiary companies bearing the name (Elite Medical Care Company - and Excellent Medical Care Company) and all of them work in the same medical field.

      Company Bylaws

      Click here

      Equity Profile

      • Authorized Capital  (^) 32,125,000
      • Issued Shares 3,212,500
      • Paid Capital  (^) 32,125,000
      • Par Value/Share 10
      • Paid Up Value/Share 10

      Last Update :2024-12-01

      Investment limits

      There are no investment limits on the company's shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on Company's bylaw and the issued Instructions by related regulators and supervisory authorities.

       

      • Company Details
      • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
      • Date Established

        2016/09/27

      • Financial Year End

        31/12

      • Listing Date

        2024/12/01

      • External Auditors

        [United Accountants for Professional Consulting (RSM)]

      • ISIN CODE

        SA165GM4M813

      • Number of Employees

        150

      • Chairman

        Eid Sultan Ayed Alotaibi
        Non - Executive

        Eid Sultan Ayed Alotaibi
        • BD Session Start
          2022-07-28
          Designation
          Chairman
        • BD Session End
          2026-07-27
          Classification
          Non - Executive
      • Board of Directors

        Hani Kamal Khader Nijm Deputy Chairman - Non Executive

        Hani Kamal Khader Nijm
        • BD Session Start
          2022-07-28
          Designation
          Board of Directors
        • BD Session End
          2026-07-27
          Classification
          Deputy Chairman - Non Executive

        Abdullah Nasser Badr Al Badr Non - Executive

        Abdullah Nasser Badr Al Badr
        • BD Session Start
          2022-07-28
          Designation
          Board of Directors
        • BD Session End
          2026-07-27
          Classification
          Non - Executive

        Jamal Mutheb Wqayan Al Otaibi Non - Executive

        Jamal Mutheb Wqayan Al Otaibi
        • BD Session Start
          2022-07-28
          Designation
          Board of Directors
        • BD Session End
          2026-07-27
          Classification
          Non - Executive

        Jameel Mutheb Wqayan Al Otaibi Executive

        Jameel Mutheb Wqayan Al Otaibi
        • BD Session Start
          2022-07-28
          Designation
          Board of Directors
        • BD Session End
          2026-07-27
          Classification
          Executive

        Mushari Thawab Matar Almotairi Non - Executive

        Mushari Thawab Matar Almotairi
        • BD Session Start
          2022-07-28
          Designation
          Board of Directors
        • BD Session End
          2026-07-27
          Classification
          Non - Executive

        Fahd Mishal Mamdouh Al Ali Non - Executive

        Fahd Mishal Mamdouh Al Ali
        • BD Session Start
          2023-10-04
          Designation
          Board of Directors
        • BD Session End
          2026-07-27
          Classification
          Non - Executive
      • Senior Executives

        Jameel Mutheb Wqayan Al Otaibi CEO

        Jameel Mutheb Wqayan Al Otaibi
        • BD Session Start
          2024-12-05
          Designation
          Senior Executives
        • BD Session End
          -
          Classification
          CEO

        Khaled Samir Ahmed Ali CFO

      Khaled Samir Ahmed Ali
      • BD Session Start
        2022-08-05
        Designation
        Senior Executives
      • BD Session End
        -
        Classification
        CFO

      Investor Relations

      Contact Name:

      Ahmed Awad Fahmy Jibril

      Company Address:

      Riyadh, 7948 As Sahra Almaghrbiyyah street, Alnafel district, 3139

      Contact Details:

      Telephone: 0112317684
      Fax : 0112317685
      Email : ahmed.awad@janamd.com

      Company Website:

      www.janamd.com.sa


      Add To Watchlist
      In your Watchlist
      Add To Watchlist

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.